Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Resources
  • Blog

Revvityブログ

発見から治療までのイノベーションを促進

Latest

PIWI-interacting RNAs, a unique class of small RNAs.

NGS August 29, 2025 - 4 min read
Read
Cell and Gene Therapy

Cell and gene therapy gets on point with base editors.

February 19, 2025 - 6 min read
Read
Cancer

Lentiviral sgRNA CRISPR screening in primary human immune cells.

February 19, 2025 - 2 min read
Read
Reproductive Health

Empowering lives: Revvity's commitment to rare disease awareness.

February 19, 2025 - 3 min read
Read
Biologics

Innovative approaches to combat ADC resistance.

February 18, 2025 - 3 min read
Read
Cell and Gene Therapy

Base editing goes big: A role in functional pooled screening.

February 14, 2025 - 4 min read
Read
Cell and Gene Therapy

Exploring the potential of base editing for sickle cell disease.

February 14, 2025 - 4 min read
Read
Cell and Gene Therapy

Revvity supports Abata Therapeutics to impact the trajectory of autoimmune disease with engineered Treg cell therapies.

February 7, 2025 - 1 min read
Read
Disease Research, Biobanking, Understanding Biology

What to consider when selecting a centrifuge for your lab.

January 24, 2025 - 3 min read
Read
Cancer

Considerations for engineering a successful knockout cell line generation.

January 17, 2025 - 1 min read
Read
Cancer

Homology-directed repair with a plasmid donor: considerations for successful HDR experimental design.

January 15, 2025 - 4 min read
Read

Pagination

  • First page
  • Previous page
  • …
  • ページ 5
  • ページ 6
  • ページ 7
  • ページ 8
  • ページ 9
  • ページ 10
  • ページ 11
  • ページ 12
  • ページ 13
  • …
  • Next page
  • Last page

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.